Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases
Year: 2009
Type: article
Abstract: isolated in Greece since 2002, constitute the majority of mul-tiresistant clinical isolates of this species found in most Greek hospitals (9). Moreover, following reports on Klebsiella pneu-moniae carbapenemase (KPC)-producing isolates from Greek patients transferred to other European countries (2, 10), a nationwide surveillance revealed a parallel epidemic of KPC-2 producers (4). Consequently, clinical laboratories were re-quired to screen all K. pneumoniae isolates displaying reduced susceptibility to carbapenems (MIC of imipenem 1 g/ml) by both EDTA- and boronic acid-imipenem combined disk tests (3, 8). Potential carbapenemase producers were sent to
DOI: 10.1128/aac.00690-09
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2059323013
